Terms of compulsory licenses granted

Further to the recent decision in India and the post here IP Komodo thought it helpful to compare known compulsory license terms (known from the media reports at least). Any additional information is welcome, to update, add to or correct this.

Country	Date	compound	Patentee	Royalty	Purpose	Term
Indonesia	5.10.04	lamivudine	GSK	0.5% of the net sales price	for government use	Patent expiry 2011
Indonesia	5.10.04	nevirapine	Boehringer Ingelheim	0.5% of the net sales price	for government use	Patent expiry 2012
Thailand	25.1.07	efavirenz	Merck	0.5% of the original cost of the drug	public non-commercial use for importation and local production
Thailand	25.1.07	opinavir/ritonavir	Abbott		public non-commercial use for importation and local production
Thailand	25.1.07	clopidogrelc	Sanofi-Aventis & Bristol-Myers Squibb.		public non-commercial use for importation and local production
India	9.3.12	sorafenib	Bayer	6% of net sales (up to max. price of 8880 Rps/pack)	Manufacture by NATCO only in India.	Patent expiry